Literature DB >> 10543525

Repair of cor triatriatum associated with partially unroofed coronary sinus.

J A van Son1, R Autschbach, F W Mohr.   

Abstract

A young patient with cor triatriatum, secundum atrial septal defect, persistent left superior vena cava, partially unroofed coronary sinus, and moderate tricuspid regurgitation was documented to have both a left-to-right shunt from the common pulmonary venous chamber to the right atrium and a right-to-left shunt from the partially unroofed coronary sinus to the left atrium. Resection of the membrane dividing the left atrium, closure of the atrial septal defect and the partially unroofed coronary sinus with pericardial patches, and a tricuspid annuloplasty resulted in an excellent hemodynamic result.

Entities:  

Mesh:

Year:  1999        PMID: 10543525     DOI: 10.1016/s0003-4975(99)00734-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Coexistence of three rare congenital heart defects in a single patient: a unique case with important embryologic implications.

Authors:  Jonathan Rhodes; Emile A Bacha; Robet L Geggel
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

2.  Cor triatriatum sinister with dilated coronary sinus from persistent left superior vena cava: a novel operative approach.

Authors:  Tsuyoshi Kaneko; Emmanouil Tsounias; William I Douglas; Felix W Tsai
Journal:  Pediatr Cardiol       Date:  2011-03-27       Impact factor: 1.655

3.  Wolff-Parkinson-White syndrome with an unroofed coronary sinus without persistent left superior vena cava treated with catheter cryoablation.

Authors:  Andrei Catanchin; Eduardo Castellanos; Jahangiri Marjan; David Ward
Journal:  Indian Pacing Electrophysiol J       Date:  2008-08-01

4.  Cor triatriatum with unroofed coronary sinus and persistent left superior vena cava associated with atrial tachycardia.

Authors:  T Sato; K Suzuki; J Umemura; Y Takahashi; K Tomimoto
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.